| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aliphatic amine oxidase activity | 6.63e-05 | 4 | 67 | 2 | GO:0052595 | |
| GeneOntologyBiologicalProcess | neural crest cell migration | 4.11e-05 | 62 | 64 | 4 | GO:0001755 | |
| GeneOntologyBiologicalProcess | mesenchymal cell migration | 4.66e-05 | 64 | 64 | 4 | GO:0090497 | |
| Domain | - | 3.68e-05 | 3 | 66 | 2 | 2.70.98.20 | |
| Domain | Cu_amine_oxidase_N3 | 3.68e-05 | 3 | 66 | 2 | IPR015802 | |
| Domain | Cu_amine_oxidase_N2 | 3.68e-05 | 3 | 66 | 2 | IPR015800 | |
| Domain | Cu_amine_oxidN2 | 3.68e-05 | 3 | 66 | 2 | PF02727 | |
| Domain | Cu_amine_oxidN3 | 3.68e-05 | 3 | 66 | 2 | PF02728 | |
| Domain | Cu_amine_oxidase_N-reg | 3.68e-05 | 3 | 66 | 2 | IPR016182 | |
| Domain | Cu_amine_oxid | 3.68e-05 | 3 | 66 | 2 | PF01179 | |
| Domain | Cu_amine_oxidase_C | 3.68e-05 | 3 | 66 | 2 | IPR015798 | |
| Domain | COPPER_AMINE_OXID_1 | 3.68e-05 | 3 | 66 | 2 | PS01164 | |
| Domain | COPPER_AMINE_OXID_2 | 3.68e-05 | 3 | 66 | 2 | PS01165 | |
| Domain | Cu_amine_oxidase | 7.35e-05 | 4 | 66 | 2 | IPR000269 | |
| Domain | Semaphorin | 2.24e-03 | 20 | 66 | 2 | IPR027231 | |
| Domain | Sema | 5.35e-03 | 31 | 66 | 2 | SM00630 | |
| Domain | Semap_dom | 5.35e-03 | 31 | 66 | 2 | IPR001627 | |
| Domain | Sema | 5.35e-03 | 31 | 66 | 2 | PF01403 | |
| Domain | FHA_DOMAIN | 5.35e-03 | 31 | 66 | 2 | PS50006 | |
| Domain | SEMA | 5.35e-03 | 31 | 66 | 2 | PS51004 | |
| Domain | PSI | 5.70e-03 | 32 | 66 | 2 | PF01437 | |
| Domain | Plexin_repeat | 5.70e-03 | 32 | 66 | 2 | IPR002165 | |
| Domain | FHA_dom | 7.17e-03 | 36 | 66 | 2 | IPR000253 | |
| Domain | - | 7.17e-03 | 36 | 66 | 2 | 2.60.200.20 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SEMA6C SEMA4F RADIL LRFN1 RPAP1 KMT5C MCM3AP AOC2 SCN8A OBSCN STRN4 UNKL STK11IP FOXK1 TBC1D17 | 2.28e-09 | 1105 | 67 | 15 | 35748872 |
| Pubmed | The unique substrate specificity of human AOC2, a semicarbazide-sensitive amine oxidase. | 3.66e-06 | 2 | 67 | 2 | 19588076 | |
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 27766585 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 27370822 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 30031096 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 29973670 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 14585497 | ||
| Pubmed | The role of the immunoescape in colorectal cancer liver metastasis. | 2.19e-05 | 4 | 67 | 2 | 34797860 | |
| Pubmed | 5.46e-05 | 6 | 67 | 2 | 25840998 | ||
| Pubmed | 7.43e-05 | 42 | 67 | 3 | 30135482 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 8.40e-05 | 736 | 67 | 8 | 29676528 | |
| Pubmed | 8.90e-05 | 233 | 67 | 5 | 37704626 | ||
| Pubmed | 1.02e-04 | 8 | 67 | 2 | 18294628 | ||
| Pubmed | Diabetes Caused by Elastase-Cre-Mediated Pdx1 Inactivation in Mice. | 2.38e-04 | 12 | 67 | 2 | 26887806 | |
| Pubmed | TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. | 2.38e-04 | 12 | 67 | 2 | 16260493 | |
| Pubmed | 4.31e-04 | 16 | 67 | 2 | 31669249 | ||
| Pubmed | 4.31e-04 | 16 | 67 | 2 | 19487660 | ||
| Pubmed | 4.31e-04 | 16 | 67 | 2 | 28283561 | ||
| Pubmed | 4.88e-04 | 17 | 67 | 2 | 17928203 | ||
| Pubmed | 5.48e-04 | 18 | 67 | 2 | 23616538 | ||
| Pubmed | Islet Cells Serve as Cells of Origin of Pancreatic Gastrin-Positive Endocrine Tumors. | 5.48e-04 | 18 | 67 | 2 | 26169832 | |
| Pubmed | Pancreas-specific Cre driver lines and considerations for their prudent use. | 5.48e-04 | 18 | 67 | 2 | 23823474 | |
| Pubmed | 5.48e-04 | 18 | 67 | 2 | 17537793 | ||
| Pubmed | A dosage-dependent requirement for Sox9 in pancreatic endocrine cell formation. | 5.48e-04 | 18 | 67 | 2 | 18723011 | |
| Pubmed | Circular rapid amplification of cDNA ends for high-throughput extension cloning of partial genes. | 5.82e-04 | 84 | 67 | 3 | 15203218 | |
| Pubmed | 6.12e-04 | 19 | 67 | 2 | 15051154 | ||
| Pubmed | 6.79e-04 | 20 | 67 | 2 | 20413507 | ||
| Pubmed | NKX6 transcription factor activity is required for alpha- and beta-cell development in the pancreas. | 7.50e-04 | 21 | 67 | 2 | 15944193 | |
| Pubmed | Motor neurons use push-pull signals to direct vascular remodeling critical for their connectivity. | 7.50e-04 | 21 | 67 | 2 | 36240771 | |
| Pubmed | 7.50e-04 | 21 | 67 | 2 | 31875961 | ||
| Pubmed | 9.01e-04 | 23 | 67 | 2 | 19805515 | ||
| Pubmed | 9.01e-04 | 23 | 67 | 2 | 22792062 | ||
| Pubmed | 9.82e-04 | 24 | 67 | 2 | 20448286 | ||
| Pubmed | A semaphorin code defines subpopulations of spinal motor neurons during mouse development. | 9.82e-04 | 24 | 67 | 2 | 15869472 | |
| Pubmed | Gene network analysis in a pediatric cohort identifies novel lung function genes. | 9.82e-04 | 24 | 67 | 2 | 24023788 | |
| Pubmed | 9.82e-04 | 24 | 67 | 2 | 23852729 | ||
| Pubmed | 1.07e-03 | 25 | 67 | 2 | 26534984 | ||
| Pubmed | 1.15e-03 | 26 | 67 | 2 | 28193997 | ||
| Pubmed | 1.34e-03 | 28 | 67 | 2 | 27740873 | ||
| Pubmed | 1.44e-03 | 29 | 67 | 2 | 33527355 | ||
| Pubmed | Noggin is required for correct guidance of dorsal root ganglion axons. | 1.44e-03 | 29 | 67 | 2 | 12435358 | |
| Pubmed | Genetic polymorphisms in adaptive immunity genes and childhood acute lymphoblastic leukemia. | 1.44e-03 | 29 | 67 | 2 | 20716621 | |
| Pubmed | 1.52e-03 | 117 | 67 | 3 | 17145500 | ||
| Pubmed | 1.75e-03 | 32 | 67 | 2 | 22514301 | ||
| Pubmed | 1.86e-03 | 33 | 67 | 2 | 16951258 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 3.39e-04 | 1192 | 67 | 8 | chr19q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | 6.49e-04 | 473 | 67 | 5 | chr17q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7p22 | 1.02e-03 | 134 | 67 | 3 | chr7p22 | |
| Cytoband | 17q25 | 1.50e-03 | 39 | 67 | 2 | 17q25 | |
| Cytoband | 7p22.1 | 2.17e-03 | 47 | 67 | 2 | 7p22.1 | |
| Cytoband | 19q13.1 | 2.96e-03 | 55 | 67 | 2 | 19q13.1 | |
| Cytoband | 17q21 | 3.87e-03 | 63 | 67 | 2 | 17q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p16 | 4.26e-03 | 222 | 67 | 3 | chr4p16 | |
| Cytoband | 17q21.2 | 4.75e-03 | 70 | 67 | 2 | 17q21.2 | |
| GeneFamily | Cyclophilin peptidylprolyl isomerases | 1.10e-03 | 19 | 47 | 2 | 909 | |
| GeneFamily | Immunoglobulin like domain containing|Semaphorins | 1.22e-03 | 20 | 47 | 2 | 736 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-07 | 172 | 67 | 6 | 33c201aaa98acbf1901b6fa6ce0d3ff8012a4d94 | |
| ToppCell | facs-Lung-24m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.61e-07 | 185 | 67 | 6 | a6cd90f8f30c7bdf66958cf403e73c193aa32f5e | |
| ToppCell | facs-Lung-24m-Mesenchymal-myofibroblast-pericyte_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.61e-07 | 185 | 67 | 6 | 5053f932e2adfcf4d6faaecff2999ac53d8d7aa5 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.32e-06 | 167 | 67 | 5 | 7abc785e688a384672d7fb5a62d32538fe7e5a51 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.32e-06 | 167 | 67 | 5 | d50311b1f66f143bae4c4cf50e2e9b13c85d6920 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.50e-06 | 174 | 67 | 5 | a9c6edf5c3fc119c24425f921c5566a8356c30fe | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal-kidney_interstitial_fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.87e-06 | 181 | 67 | 5 | c7f5aedcb74c21fb587a95a16d700e2a38a380ee | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal-kidney_interstitial_fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.87e-06 | 181 | 67 | 5 | 0ec9621a078d004bbd25a587757d24b5cf162959 | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.30e-06 | 183 | 67 | 5 | 0e8fb371d8eac777451c76f41d53577f5dfb740d | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.30e-06 | 183 | 67 | 5 | cbc3b00faa7e4e0dbbbc8ee105467c65241c7470 | |
| ToppCell | Nasal_Brush-Immune-Neutrophils|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.98e-06 | 186 | 67 | 5 | f5aa91dbef29f7efa2b9a728c6539d7541340cd4 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.01e-05 | 53 | 67 | 3 | d55030028f9ac970afb343ef6e1c41ab4bb2ae53 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L4-L4_IT_VISp_Rspo1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.01e-05 | 53 | 67 | 3 | c8af66760dac32cdbc0f17d1c004596c847f16f6 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-Tfh|Liver / Manually curated celltypes from each tissue | 8.99e-05 | 156 | 67 | 4 | 85bc34ff507f9a66c6e3ba7a3ffd5416d0073ccf | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D122|Adult / Lineage, Cell type, age group and donor | 1.14e-04 | 166 | 67 | 4 | be284e2e596390f05305c7bcfc316f87b963fc0b | |
| ToppCell | Basal_cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.25e-04 | 170 | 67 | 4 | 776d4224a682b6c648041827efd69794f88906f0 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 173 | 67 | 4 | c31076c725f4cd912c56903592a2d9356ae59f54 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 173 | 67 | 4 | 7c5e4809205ce1a0a301c15442af00a2e2b9b301 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 173 | 67 | 4 | a4ed191cfdf6588b7f3672995bf0a4fe9e4b8df6 | |
| ToppCell | Influenza_Severe-B_intermediate|Influenza_Severe / Disease group and Cell class | 1.37e-04 | 174 | 67 | 4 | 4276bdaac53aebd3084323a90ecde572d3177446 | |
| ToppCell | facs-Lung-24m-Mesenchymal-myofibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.37e-04 | 174 | 67 | 4 | a7ade7372e83edd4e3983e77f8417b51f0b47340 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Degenerative_Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-04 | 174 | 67 | 4 | 46bd0ef7d0541386de7a901d85d53d0176dc92bf | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.37e-04 | 174 | 67 | 4 | 4da79da7a09ee1e345102c5331675ebcdbe56171 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.43e-04 | 176 | 67 | 4 | 8e7f38de8bf68077e2138f4d06c1f55b0fd096cc | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.43e-04 | 176 | 67 | 4 | ed575330a08a6748ea4b28433292c8cfd157d444 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.49e-04 | 178 | 67 | 4 | a107dd98a07086ed0429116095ecda60c9dbef1e | |
| ToppCell | T_cells-GZMK+_CD8+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.53e-04 | 179 | 67 | 4 | 798f208014f2229c597934775646ddbbacf94b69 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_NK-T_NK-ILC_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.56e-04 | 180 | 67 | 4 | 27672ac6a02172a31851f18decb9acffa8f5a703 | |
| ToppCell | BAL-Control-cDC_8|Control / Compartment, Disease Groups and Clusters | 1.59e-04 | 181 | 67 | 4 | f370161afef2ec827a7b194c06abb9ac1a507cbb | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.63e-04 | 182 | 67 | 4 | 9966f42c338cbd471efa8ffc765a6ce93693aa75 | |
| ToppCell | facs-GAT-Fat-24m-Lymphocytic|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-04 | 183 | 67 | 4 | 377c2c6fcb2fd41396dd7a7a90e9d7ccafccf2f0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-04 | 183 | 67 | 4 | 83592c332b1e82673f993d37c7f480befdc3dcda | |
| ToppCell | facs-GAT-Fat-24m-Lymphocytic-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-04 | 183 | 67 | 4 | f0a6f4f8563491c83fb991b9fb81e75fec7d1ace | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.66e-04 | 183 | 67 | 4 | 274f274cf60daa30d6a4cd603a3af7823bfb8016 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.70e-04 | 184 | 67 | 4 | 607b55022de21ddb6a2d75e085df76df7abf6624 | |
| ToppCell | myeloid-Dendritic_cell-Plasmacytoid_dendritic_cell|Dendritic_cell / Lineage, cell class and subclass | 1.77e-04 | 186 | 67 | 4 | 858134580a09ed8a5eb6d6413d8ca9265904dfc1 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.92e-04 | 190 | 67 | 4 | 0adb24dafa077156bbc73a8d8cbf3d9eeb6e08df | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.92e-04 | 190 | 67 | 4 | 05455775845f4ded5c27e7b83242078d23162aaf | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.00e-04 | 192 | 67 | 4 | 8899d81306770adda893b5e146df1253971754c5 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.00e-04 | 192 | 67 | 4 | 26d9207e72bbef5e0046de511e2c9ff752b726f3 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.00e-04 | 192 | 67 | 4 | 5fda9a465c9f77c7fa1a3ea07a2b0374bbc23b2a | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.04e-04 | 193 | 67 | 4 | 88916d9a7d831eb52848599917c04238f8f9812b | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.04e-04 | 193 | 67 | 4 | 7fc3ab7261c88c1df71744bf5b17e8e46c4300e0 | |
| ToppCell | facs-BAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 194 | 67 | 4 | da45811ba07d746e7cba7ed78882b5d98ac7397d | |
| ToppCell | facs-BAT-Fat-3m-Mesenchymal|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 194 | 67 | 4 | 76b8512fd92014b3ecc42b0a20d6d1df074cba2c | |
| ToppCell | facs-BAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 194 | 67 | 4 | ef0fa9daecd3bf43c6cf56345928cacdbee19779 | |
| ToppCell | distal-Epithelial-Proximal_Basal|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.16e-04 | 196 | 67 | 4 | c102b28d5d1d90b9f7024cb51114276354be26a5 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.16e-04 | 196 | 67 | 4 | 547901c7a665770eff78eede69b8625b416c8186 | |
| ToppCell | distal-Epithelial-Proximal_Basal-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.16e-04 | 196 | 67 | 4 | a543d4623096cb3f9170dbf7af52381e77aa435e | |
| ToppCell | distal-3-Epithelial-Proximal_Basal|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.16e-04 | 196 | 67 | 4 | 7e1a565dd2da4f375cbce8842ba4fd6c22ac8375 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.16e-04 | 196 | 67 | 4 | 6e08d7ba67da161c2dca1a17c440ffb9d9b5bc3b | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intermediate|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.20e-04 | 197 | 67 | 4 | e2983ae16c72371fbf0e5c123de9f4d900724e5e | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.20e-04 | 197 | 67 | 4 | 1e915957ea6a4550ecb9d6ee4b232aa5800faf20 | |
| ToppCell | Bronchus_Control_(B.)|World / Sample group, Lineage and Cell type | 2.20e-04 | 197 | 67 | 4 | b6dff2ee108813e18657e2d8cf850e2423f8c8e9 | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-B-B_intermediate|Influenza_Severe / Disease, condition lineage and cell class | 2.25e-04 | 198 | 67 | 4 | ab622fee61714471af3a7be0af356e8a484dcaff | |
| ToppCell | distal-mesenchymal-Vascular_Smooth_Muscle|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.25e-04 | 198 | 67 | 4 | 8d1c74a728040386316fbdcabcdea5fb2b5a76a1 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 2.25e-04 | 198 | 67 | 4 | 0c4d2c68a42f8a9e964e2dd28092fe75f5216834 | |
| ToppCell | LPS_only-Hematopoietic_Myeloid-Dendritic_cells-pDC|LPS_only / Treatment groups by lineage, cell group, cell type | 2.25e-04 | 198 | 67 | 4 | d205dfcfe1f20e1e21bf84759e723d9e6e610a5c | |
| ToppCell | distal-mesenchymal-Vascular_Smooth_Muscle-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.25e-04 | 198 | 67 | 4 | 5080767ff55326b7d94fca27d398237c4a15c1ed | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-04 | 198 | 67 | 4 | b086af292a508a156266c2d899ba1caf820bf61c | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.29e-04 | 199 | 67 | 4 | 0019cfaa586a450c2e4952d1184a540561c8d0ba | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.33e-04 | 200 | 67 | 4 | 01522ed0b68614b1ebdf190957d44a9d48a6c6e3 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.33e-04 | 200 | 67 | 4 | 36de49593cf6ff1c9229fcceb150c1d68658a360 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.33e-04 | 200 | 67 | 4 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.33e-04 | 200 | 67 | 4 | ed093626a9cac7531a2bf02f6e345c5e84b8c060 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.33e-04 | 200 | 67 | 4 | 85c0f038bcfb42669dca2b80273b0f8a1421405e | |
| Drug | Orphenadrine hydrochloride [341-69-5]; Down 200; 13uM; PC3; HT_HG-U133A | 1.83e-06 | 197 | 67 | 7 | 3801_DN | |
| Drug | Flurandrenolide [1524-88-5]; Down 200; 9.2uM; HL60; HT_HG-U133A | 1.89e-06 | 198 | 67 | 7 | 2184_DN | |
| Drug | diphenylglyoxal bis(guanylhydrazone | 8.53e-06 | 2 | 67 | 2 | CID000357080 | |
| Drug | AC1Q77R6 | 8.53e-06 | 2 | 67 | 2 | CID000094259 | |
| Drug | DPGBG | 8.53e-06 | 2 | 67 | 2 | CID005356884 | |
| Drug | monopropionylcadaverine | 8.53e-06 | 2 | 67 | 2 | CID000194207 | |
| Drug | p-dimethylaminomethylbenzaldehyde | 8.53e-06 | 2 | 67 | 2 | CID000193251 | |
| Drug | 1-carboxymethylpyridinium | 8.53e-06 | 2 | 67 | 2 | CID000080439 | |
| Drug | isoputreanine | 8.53e-06 | 2 | 67 | 2 | CID000171763 | |
| Drug | supinidine | 8.53e-06 | 2 | 67 | 2 | CID000164663 | |
| Drug | N-(3-aminopropyl)pyrrolidin-2-one | 8.53e-06 | 2 | 67 | 2 | CID000082111 | |
| Drug | Ethamsylate [2624-44-4]; Up 200; 15.2uM; MCF7; HT_HG-U133A | 2.43e-05 | 196 | 67 | 6 | 7335_UP | |
| Drug | Nicergoline; Down 200; 8.2uM; PC3; HT_HG-U133A | 2.43e-05 | 196 | 67 | 6 | 2058_DN | |
| Drug | Vigabatrin [60643-86-9]; Down 200; 31uM; MCF7; HT_HG-U133A | 2.50e-05 | 197 | 67 | 6 | 5415_DN | |
| Drug | AC1L1B7L | 2.55e-05 | 3 | 67 | 2 | CID000026477 | |
| Drug | 3-aminopropionamide | 2.55e-05 | 3 | 67 | 2 | CID000192802 | |
| Drug | pentafluorobenzamide | 2.55e-05 | 3 | 67 | 2 | CID000069547 | |
| Drug | acisoga | 2.55e-05 | 3 | 67 | 2 | CID000129397 | |
| Drug | (+)-Cyanustine | 2.55e-05 | 3 | 67 | 2 | CID000028846 | |
| Drug | propylglyoxal | 2.55e-05 | 3 | 67 | 2 | CID000123249 | |
| Drug | 3-Hydroxycadaverine | 2.55e-05 | 3 | 67 | 2 | CID000435285 | |
| Drug | 5-fluoropentane-1,4-diamine | 2.55e-05 | 3 | 67 | 2 | CID010011890 | |
| Drug | NSD-1531 | 2.55e-05 | 3 | 67 | 2 | CID003014318 | |
| Drug | Nazlinine | 2.55e-05 | 3 | 67 | 2 | CID000126237 | |
| Drug | 5-aminopentanal | 2.55e-05 | 3 | 67 | 2 | CID000443849 | |
| Drug | necic acid | 2.55e-05 | 3 | 67 | 2 | CID006440847 | |
| Drug | AC1L34PU | 2.55e-05 | 3 | 67 | 2 | CID000134498 | |
| Drug | h202 | 2.55e-05 | 3 | 67 | 2 | CID000013826 | |
| Drug | amicarbalide | 2.55e-05 | 3 | 67 | 2 | CID000072074 | |
| Drug | N-(4-aminobutyl)aziridine | 2.55e-05 | 3 | 67 | 2 | CID000152643 | |
| Drug | C10974 | 2.55e-05 | 3 | 67 | 2 | CID000443042 | |
| Drug | alpha-difluoromethyl putrescine | 2.55e-05 | 3 | 67 | 2 | CID000135151 | |
| Drug | ketosuccinamate | 2.55e-05 | 3 | 67 | 2 | CID000439716 | |
| Drug | N-(3-aminopropyl)aziridine | 2.55e-05 | 3 | 67 | 2 | CID000014076 | |
| Drug | ethylmethylglyoxal bis(guanylhydrazone | 2.55e-05 | 3 | 67 | 2 | CID000129202 | |
| Drug | Sulfaquinoxaline sodium salt [967-80-6]; Down 200; 12.4uM; HL60; HT_HG-U133A | 2.57e-05 | 198 | 67 | 6 | 2528_DN | |
| Drug | Epiandrosterone [481-29-8]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 2.65e-05 | 199 | 67 | 6 | 5687_UP | |
| Drug | Paromomycin sulfate [1263-89-4]; Up 200; 5.6uM; PC3; HT_HG-U133A | 2.65e-05 | 199 | 67 | 6 | 4595_UP | |
| Drug | malonamate | 5.10e-05 | 4 | 67 | 2 | CID000075367 | |
| Drug | 2-aminoresorcinol | 5.10e-05 | 4 | 67 | 2 | CID000069450 | |
| Drug | Eovist (TN) | 5.10e-05 | 4 | 67 | 2 | CID009961939 | |
| Drug | AC1Q3E6A | 5.10e-05 | 4 | 67 | 2 | CID000068318 | |
| Drug | spermic acid | 5.10e-05 | 4 | 67 | 2 | CID000167029 | |
| Drug | N-acetyl-1,6-diaminohexane | 5.10e-05 | 4 | 67 | 2 | CID000162081 | |
| Drug | 3-aminooxy-2-fluoro-1-propanamine | 5.10e-05 | 4 | 67 | 2 | CID000126496 | |
| Drug | 2-Butene-1,4-diamine | 5.10e-05 | 4 | 67 | 2 | CID000148401 | |
| Drug | lanthionamine | 5.10e-05 | 4 | 67 | 2 | CID000070096 | |
| Drug | N-methylpyrrolinium | 5.10e-05 | 4 | 67 | 2 | CID000440932 | |
| Drug | dimethylpyridine | 5.10e-05 | 4 | 67 | 2 | CID000011420 | |
| Drug | 1,4-diamino-2-butyne | 5.10e-05 | 4 | 67 | 2 | CID000124159 | |
| Drug | azidopine | 7.57e-05 | 28 | 67 | 3 | CID000656406 | |
| Drug | 13-epi-12-oxo-phytodienoic acid | 8.43e-05 | 29 | 67 | 3 | CID000188366 | |
| Drug | piperideine | 8.48e-05 | 5 | 67 | 2 | CID000068161 | |
| Drug | geranylamine | 8.48e-05 | 5 | 67 | 2 | CID000160248 | |
| Drug | phenamidine | 8.48e-05 | 5 | 67 | 2 | CID000064948 | |
| Drug | NSD 1039 | 8.48e-05 | 5 | 67 | 2 | CID000193408 | |
| Drug | NSD 1024 | 8.48e-05 | 5 | 67 | 2 | CID000188951 | |
| Drug | N(8)-(2-carboxyethyl)spermidine | 8.48e-05 | 5 | 67 | 2 | CID000125245 | |
| Drug | Nsc82118 | 8.48e-05 | 5 | 67 | 2 | CID000164749 | |
| Drug | oxosparteine | 8.48e-05 | 5 | 67 | 2 | CID000097492 | |
| Drug | alpha-hydrazinohistidine | 8.48e-05 | 5 | 67 | 2 | CID000169499 | |
| Drug | perhydroazepinyl | 8.48e-05 | 5 | 67 | 2 | CID000123152 | |
| Drug | 2-fluoroputrescine | 8.48e-05 | 5 | 67 | 2 | CID000147066 | |
| Drug | pelletierine | 8.48e-05 | 5 | 67 | 2 | CID000092987 | |
| Drug | 1,4-diamino-2-butanone | 8.48e-05 | 5 | 67 | 2 | CID000151733 | |
| Drug | NSC614854 | 1.27e-04 | 6 | 67 | 2 | CID000122633 | |
| Drug | isothiouronium | 1.27e-04 | 6 | 67 | 2 | CID000031429 | |
| Drug | trihydroxyphenylalanine | 1.27e-04 | 6 | 67 | 2 | CID000591034 | |
| Drug | cyclohexanone oxime | 1.27e-04 | 6 | 67 | 2 | CID000007517 | |
| Drug | ethylglyoxal | 1.27e-04 | 6 | 67 | 2 | CID000145744 | |
| Drug | FF-705 | 1.27e-04 | 6 | 67 | 2 | CID000126643 | |
| Drug | 1,4-dimethylputrescine | 1.27e-04 | 6 | 67 | 2 | CID000162247 | |
| Drug | putreanine | 1.77e-04 | 7 | 67 | 2 | CID000161506 | |
| Drug | AC1L3Y6U | 1.77e-04 | 7 | 67 | 2 | CID000097282 | |
| Drug | GYKI 11.121 | 1.77e-04 | 7 | 67 | 2 | CID000193769 | |
| Drug | p-dimethylaminomethylbenzylamine | 1.77e-04 | 7 | 67 | 2 | CID000193714 | |
| Drug | 2-hydrazinopyridine | 1.77e-04 | 7 | 67 | 2 | CID000078645 | |
| Drug | AC1L28PE | 1.77e-04 | 7 | 67 | 2 | CID000067954 | |
| Drug | tele-methylhistamine | 1.91e-04 | 38 | 67 | 3 | CID000003614 | |
| Drug | hyamine hydroxide | 2.36e-04 | 8 | 67 | 2 | CID000014842 | |
| Drug | 1,2-diaminoguanidine | 2.36e-04 | 8 | 67 | 2 | CID000170039 | |
| Drug | NSC-356893 | 2.36e-04 | 8 | 67 | 2 | CID000434770 | |
| Drug | Z H-H | 2.36e-04 | 8 | 67 | 2 | CID000004657 | |
| Drug | Q 192 | 2.36e-04 | 8 | 67 | 2 | CID000077317 | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Up 200; 11uM; MCF7; HT_HG-U133A | 2.38e-04 | 189 | 67 | 5 | 3408_UP | |
| Drug | Pinacidil [85371-64-8]; Down 200; 16.4uM; MCF7; HT_HG-U133A | 2.50e-04 | 191 | 67 | 5 | 5456_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; HL60; HT_HG-U133A | 2.62e-04 | 193 | 67 | 5 | 2682_UP | |
| Drug | Simvastatin [79902-63-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 2.68e-04 | 194 | 67 | 5 | 4828_UP | |
| Drug | Cyclizine hydrochloride [303-25-3]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 2.68e-04 | 194 | 67 | 5 | 5525_UP | |
| Drug | Phensuximide [86-34-0]; Down 200; 21.2uM; MCF7; HT_HG-U133A | 2.68e-04 | 194 | 67 | 5 | 3521_DN | |
| Drug | (S)-propranolol hydrochloride [4199-10-4]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 2.75e-04 | 195 | 67 | 5 | 3523_DN | |
| Drug | SB 202190; Down 200; 1uM; MCF7; HT_HG-U133A | 2.75e-04 | 195 | 67 | 5 | 6887_DN | |
| Drug | Florfenicol [73231-34-2]; Down 200; 11.2uM; HL60; HT_HG-U133A | 2.75e-04 | 195 | 67 | 5 | 3083_DN | |
| Drug | Bacitracin [1405-87-4]; Up 200; 2.8uM; MCF7; HT_HG-U133A | 2.75e-04 | 195 | 67 | 5 | 7448_UP | |
| Drug | Ozagrel hydrochloride [78712-43-3]; Down 200; 15.2uM; MCF7; HT_HG-U133A | 2.75e-04 | 195 | 67 | 5 | 3503_DN | |
| Drug | Lidoflazine [3416-26-0]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 2.75e-04 | 195 | 67 | 5 | 3201_DN | |
| Drug | Spaglumic acid [4910-46-7]; Down 200; 13.2uM; HL60; HT_HG-U133A | 2.75e-04 | 195 | 67 | 5 | 2962_DN | |
| Drug | Estropipate [7280-37-7]; Down 200; 9.2uM; PC3; HT_HG-U133A | 2.81e-04 | 196 | 67 | 5 | 4472_DN | |
| Drug | N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Up 200; 25.2uM; MCF7; HT_HG-U133A | 2.81e-04 | 196 | 67 | 5 | 3930_UP | |
| Drug | 16-phenyl tetranor Prostaglandin E2; Down 200; 10uM; MCF7; HT_HG-U133A | 2.81e-04 | 196 | 67 | 5 | 7541_DN | |
| Disease | pulmonary tuberculosis (is_marker_for) | 2.70e-03 | 36 | 63 | 2 | DOID:2957 (is_marker_for) | |
| Disease | human immunodeficiency virus infectious disease (is_marker_for) | 2.70e-03 | 36 | 63 | 2 | DOID:526 (is_marker_for) | |
| Disease | spondylosis | 3.32e-03 | 40 | 63 | 2 | MONDO_0002253 | |
| Disease | triacylglycerol 56:6 measurement | 3.83e-03 | 43 | 63 | 2 | EFO_0010433 | |
| Disease | total cholesterol measurement, triglyceride measurement, low density lipoprotein cholesterol measurement, high density lipoprotein cholesterol measurement | 4.95e-03 | 49 | 63 | 2 | EFO_0004530, EFO_0004574, EFO_0004611, EFO_0004612 | |
| Disease | HOMA-B | 6.19e-03 | 55 | 63 | 2 | EFO_0004469 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PDPTCREPAHSELLD | 161 | Q66K41 | |
| VEDRHSPPLCASPSD | 176 | P0C6C1 | |
| CVLPDSLPPSPDRHS | 276 | Q76N32 | |
| PPASRAAPEEHCRRG | 2011 | Q8IYW2 | |
| TLLEARRPHVCPGDP | 246 | Q8TAV3 | |
| RRGDVHSLLSNPPDP | 776 | Q9P2G1 | |
| RDPACSGPKDGPHRD | 741 | Q9BZ11 | |
| RPHTLDGRNIDPKPC | 71 | Q96EP5 | |
| SLDGPHEDPRCLSRP | 251 | Q9NRI5 | |
| AHLDRGSPPPAREAL | 111 | Q16853 | |
| RRCLGPPAAHSLSEE | 121 | Q32P28 | |
| HSRVCLTSPDPDDPL | 336 | P54829 | |
| REDPERSSCHGLPPT | 451 | Q12851 | |
| DGHLEAPSCPLAPRD | 841 | Q96JH8 | |
| LAHLDRGSPPPAREA | 106 | O75106 | |
| ICTHRPDPTGPGLDR | 13861 | Q8WXI7 | |
| PEAERFCHRLPPGSL | 36 | Q8NHW3 | |
| PSHRSVCGRDLAPLP | 106 | Q9NTI7 | |
| LGPRACVHPSPLRRD | 281 | Q86Y97 | |
| VLSGDRQPPHSRPCL | 356 | Q86YD7 | |
| REHPPACLSDPSLGT | 56 | Q8IUS5 | |
| TTAGDPAPCRPLRAH | 516 | Q9P244 | |
| EAECHRTRETLPPFP | 271 | O95671 | |
| DSDPLSRGDHPPDKR | 311 | O60318 | |
| PHPPEDDSSLRAERG | 701 | Q96Q04 | |
| PEPTCGRSPLHLAVE | 236 | Q15653 | |
| PRSAQPLRPEDGHCS | 271 | Q15116 | |
| DLLELHCEAPRGSPP | 581 | Q96RD9 | |
| LGRLLHDPPEDCRSD | 36 | Q9BRP0 | |
| HARCGSPSLPERPLQ | 11 | Q8IXY8 | |
| ICHRGTRSPSPSDPD | 256 | Q7RTS3 | |
| PDSPSLGVARHLCRD | 6771 | Q5VST9 | |
| RNPAGECHRPPAADS | 26 | Q66K79 | |
| DGPFAVCHDTLDPRP | 681 | Q9Y6R7 | |
| PGLRDDESCPDLPHS | 1436 | Q05707 | |
| HRDLGPDTRPPECIE | 161 | Q14435 | |
| LPDCPRVSAGTDRHE | 361 | Q8WUF8 | |
| TPECLSREGSPIPHD | 436 | P85037 | |
| SREPDDRRPLGHFPD | 636 | O75342 | |
| PPGPGRALLECDHLR | 26 | Q9NRM0 | |
| DTPRSLCLAPRDHSP | 406 | Q18PE1 | |
| ESHLSLCPVAPRPEG | 551 | Q86VB7 | |
| GDTCPRPHPSGLREE | 6 | A2RUB1 | |
| LSPPPERCGLRSVDH | 776 | Q8N1F8 | |
| LDPCPSPAHIRLTGA | 746 | O95754 | |
| LFRSRPAHSLPPGED | 461 | Q15750 | |
| LSDHPLDQGPRCPAR | 66 | Q8IXR5 | |
| LGDSLEPHPGECPRE | 21 | Q8NDX1 | |
| LCDRDSPFGSIHPRD | 366 | Q9HAT2 | |
| PGLHDPCERDPTDAL | 281 | Q96SI9 | |
| FRLLCSAHEAPGPAP | 76 | Q6NVH7 | |
| DPESGDRCPELDAHP | 341 | O15079 | |
| DRCPELDAHPSGPRD | 346 | O15079 | |
| HEPPSRPCGLLDEDG | 691 | O94762 | |
| RPQLCHSEPTRGAEP | 96 | Q9HA65 | |
| CPSSAKEEPRHREPL | 581 | Q9H0M4 | |
| CDEPRRTLHPAPSPS | 21 | Q8IZW8 | |
| PLPRAGHCAPSEAIE | 96 | Q15257 | |
| NRPPDCSLDKEHPGS | 1716 | Q9UQD0 | |
| GPSPRPHECASPLRL | 806 | Q9H3T2 | |
| RARPSPGHCLPEDED | 76 | Q9BWH6 | |
| AHGPLDLRPPVCDVR | 141 | Q9H9P5 | |
| SCPSAEPAHPLGELR | 146 | O15060 | |
| DLHGDLLSPRRPPDD | 421 | A2A288 | |
| RRCSAPGESPKERHP | 81 | Q9Y2P0 | |
| APDPRRCTVDGSPHE | 331 | Q9NRL3 | |
| LRARGPQCLPSDHAP | 276 | Q9UPU9 | |
| RSLSGCPHKDRIPPE | 461 | Q01538 | |
| DCRVHPGPVSPAREA | 316 | Q14957 |